Arcus Biosciences Inc (RCUS) Insider Trading
- $564,820,580.75
- $9,163,971.45
- Feb. 27, 2025
- Jennifer Jarrett
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Feb. 27, 2025 | CEO | 19,800 | $10.18 | Buy | $201,564.00 | |
Feb. 27, 2025 | Director | 20,000 | $10.06 | Buy | $201,200.00 | |
Dec. 31, 2024 | CFO | 3,594 | $15.00 | Sell | $53,910.00 | |
Dec. 2, 2024 | CAO | 201 | $15.32 | Sell | $3,079.32 | |
March 27, 2024 | COO | 11,551 | $17.55 | Sell | $202,720.05 | |
March 18, 2024 | COO | 13,449 | $17.92 | Sell | $241,006.08 | |
Feb. 26, 2024 | President | 3,900 | $20.06 | Sell | $78,234.00 | |
Feb. 26, 2024 | COO | 24,555 | $20.07 | Sell | $492,818.85 | |
Jan. 29, 2024 | Major Shareholder | 15,238,095 | $21.00 | Buy | $319,999,995.00 | |
Jan. 2, 2024 | President | 6,975 | $20.09 | Sell | $140,127.75 | |
Jan. 2, 2024 | CFO | 2,004 | $20.00 | Sell | $40,080.00 | |
Dec. 22, 2023 | COO | 21,521 | $17.76 | Sell | $382,212.96 | |
Sept. 22, 2023 | COO | 21,369 | $19.99 | Sell | $427,166.31 | |
July 28, 2023 | COO | 45,000 | $20.25 | Sell | $911,250.00 | |
July 3, 2023 | CAO | 1,018 | $20.41 | Sell | $20,777.38 | |
June 28, 2023 | Major Shareholder | 1,010,000 | $19.26 | Buy | $19,452,600.00 | |
June 22, 2023 | COO | 12,437 | $19.12 | Sell | $237,795.44 | |
June 16, 2023 | COO | 12,563 | $19.35 | Sell | $243,094.05 | |
March 16, 2023 | COO | 8,729 | $16.81 | Sell | $146,734.49 | |
Jan. 26, 2023 | COO | 300 | $23.56 | Sell | $7,068.00 | |
Dec. 16, 2022 | General Counsel | 2,523 | $30.75 | Sell | $77,582.25 | |
Dec. 16, 2022 | COO | 16,482 | $30.75 | Sell | $506,821.50 | |
Dec. 16, 2022 | President | 4,436 | $30.75 | Sell | $136,407.00 | |
Dec. 16, 2022 | CFO | 2,453 | $30.75 | Sell | $75,429.75 | |
Dec. 16, 2022 | CEO | 13,043 | $30.75 | Sell | $401,072.25 | |
Sept. 16, 2022 | COO | 12,677 | $26.28 | Sell | $333,151.56 | |
June 16, 2022 | General Counsel | 1,400 | $20.72 | Sell | $29,008.00 | |
June 16, 2022 | CEO | 4,241 | $20.72 | Sell | $87,873.52 | |
June 16, 2022 | President | 2,333 | $20.72 | Sell | $48,339.76 | |
June 16, 2022 | COO | 6,081 | $20.72 | Sell | $125,998.32 | |
March 16, 2022 | COO | 9,617 | $31.62 | Sell | $304,089.54 | |
Dec. 20, 2021 | COO | 34,822 | $41.48 | Sell | $1,444,416.56 | |
Dec. 16, 2021 | CFO | 485 | $39.83 | Sell | $19,317.55 | |
Dec. 16, 2021 | CEO | 2,299 | $39.82 | Sell | $91,546.18 | |
Dec. 16, 2021 | President | 865 | $39.82 | Sell | $34,444.30 | |
Dec. 16, 2021 | General Counsel | 487 | $39.82 | Sell | $19,392.34 | |
Dec. 16, 2021 | COO | 5,560 | $39.82 | Sell | $221,399.20 | |
Sept. 20, 2021 | COO | 30,634 | $35.18 | Sell | $1,077,704.12 | |
June 16, 2021 | General Counsel | 1,309 | $24.16 | Sell | $31,625.44 | |
June 4, 2021 | COO | 1,044 | $24.91 | Sell | $26,006.04 | |
April 23, 2021 | Director | 4,133 | $31.37 | Buy | $129,652.21 | |
March 31, 2021 | Director | 20,000 | $28.35 | Buy | $567,000.00 | |
March 16, 2021 | Insider | 2,127 | $35.03 | Sell | $74,508.81 | |
March 16, 2021 | COO | 8,661 | $35.03 | Sell | $303,394.83 | |
Jan. 31, 2021 | Major Shareholder | 5,650,000 | $39.00 | Buy | $220,350,000.00 | |
Dec. 16, 2020 | Insider | 2,117 | $31.35 | Sell | $66,367.95 | |
Sept. 9, 2020 | CFO | 5,000 | $21.57 | Buy | $107,850.00 | |
July 31, 2020 | Insider | 200 | $19.72 | Buy | $3,944.00 | |
June 28, 2019 | President | 15,000 | $7.59 | Buy | $113,850.00 | |
June 12, 2019 | Director | 20,000 | $8.20 | Buy | $164,000.00 |
Insiders are both buying and selling Arcus Biosciences Inc stock.
The insider traders at Arcus Biosciences Inc are: Jennifer Jarrett, Terry J Rosen, Juan C Jaen, Robert C Goeltz II, Kathryn E Falberg, William Grossman, Carolyn C Tang, Yasunori Kaneko, Gilead Sciences, Inc., Alexander Azoy, Carolyn C. Tang, and Gilead Sciences Inc
The most active insider trader at Arcus Biosciences Inc is Jennifer Jarrett with 19 trades.
Jennifer Jarrett has sold the most Arcus Biosciences Inc stock with a total value of $7,837,567.95.
Gilead Sciences, Inc. has bought the most Arcus Biosciences Inc stock with a total value of $659,452,590.00.
The most recent insider trade for Arcus Biosciences Inc was on Feb. 27, 2025.
The single biggest insider buy for Arcus Biosciences Inc was from Gilead Sciences, Inc. with a total value of $319,999,995.00 on Jan. 29, 2024.
The single biggest insider sell for Arcus Biosciences Inc was from Jennifer Jarrett with a total value of $1,444,416.56 on Dec. 20, 2021.